Why the study?
The relationships between body weight, CT-assessed abdominal adipose tissue, and glycemic metabolic profiles following laparoscopic sleeve gastrectomy in obese Japanese patients needed investigation.
Does laparoscopic sleeve gastrectomy improve body weight, abdominal fat volume, and glucose metabolism in obese Japanese patients?
Does laparoscopic sleeve gastrectomy improve body weight, abdominal fat volume, and glucose metabolism in obese Japanese patients?
After sleeve gastrectomy, total body weight loss is associated with subcutaneous fat loss and visceral fat density changes, whereas glucose metabolism improvements are specifically linked to visceral fat loss.
Subcutaneous and visceral fat changes associate with weight loss and glycemic gains after sleeve gastrectomy; hypothesis-generating and should not yet change practice.
In this study, we investigated the relationships between body weight (BW), computed tomography (CT)-assessed abdominal adipose tissue, and the glycemic metabolic profile in obese Japanese patients following laparoscopic sleeve gastrectomy (LSG). This study analyzed adipose tissue compartments using CT methods before and 1 year after LSG. Thirty obese patients were studied, and variables measured included visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), density of VAT (VAT-D), and density of SAT (SAT-D). We also examined the parameters in patients according to whether they had type-2 diabetes (T2DM). LSG induced significant losses in BW, SAT, and VAT after LSG. Additionally, SAT-D and VAT-D both increased and fasting plasma glucose (FPG) and HbA1c, but not C-peptide, decreased after surgery. ΔSAT and ΔVAT were positively related, and ΔSAT-D and ΔVAT-D were negatively related to ΔBW and/or FPG. Furthermore, a multivariate regression model showed that total BW loss (TBWL) was closely related to ΔSAT (β = 0.84; p < 0.001) and ΔVAT-D (β = -0.45; p < 0.05) and improvement of FPG was related to ΔVAT (β = 0.61; p < 0.05) after LSG. Finally, ΔFPG was correlated with ΔVAT in 16 T2DM patients (r = 0.58; p < 0.05) but not in non-T2DM patients. TBWL was related to ΔSAT and ΔVAT-D, and improvement of FPG was related to ΔVAT in obese Japanese patients after LSG.
No takes yet. Share an insight, caveat, or question.
Ozeki et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: